Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan-Reference-Cited by-同舟云学术

Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan

Published:2010 Issue:10 Volume:2 Page:374
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:en
Short-container-title:WJH

Author:

Sumida Yoshio

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference80 articles.

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-438.

2. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis 1986;8:283-298.

3. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123:1705-1725.

4. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-1219.

5. Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007;22:775-777.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan;International Journal of Molecular Sciences;2020-06-18

2. Alkoholische Lebererkrankungen (ALD);Pathologie;2020

3. Blood-based novel biomarkers for nonalcoholic steatohepatitis;Biomarkers in Medicine;2018-05

4. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease;Journal of Digestive Diseases;2016-11

5. S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis;PLOS ONE;2015-05-19